Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.55 is 13% above its 5-year average of 4.92, around the middle of its 5-year range (2.39–12.27).
As of the fiscal period ended Tuesday, June 30, 2026. 35.75% above its 12-month average of 4.09.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.55.
CURRENT RATIO
5.55
CURRENT RATIO AVG TTM
4.09
CURRENT RATIO AVG 3Y
3.93
CURRENT RATIO AVG 5Y
4.92
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+35.75%
CURRENT VS 3Y AVG
+41.26%
CURRENT VS 5Y AVG
+12.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+48.08%
vs the sector median at left
Cardiol Therapeutics Inc.
Market Cap
$151.01M
Current Ratio
5.55
TTM Avg
4.09
3Y Avg
3.93
5Y Avg
4.92
Market Cap
$149.36M
Current Ratio
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$148.73M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$148.64M
Current Ratio
7.51
TTM Avg
6.60
3Y Avg
4.97
5Y Avg
4.99
Market Cap
$153.58M
Current Ratio
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
Market Cap
$148.27M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$146.62M
Current Ratio
2.47
TTM Avg
5.27
3Y Avg
13.16
5Y Avg
16.37
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiol Therapeutics Inc. (CRDL) | $151.01M | 5.55 | 4.09 | 3.93 | 4.92 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 9.71 | 4.67 | 6.04 | 19.74 |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | 0.82 | 5.49 | 4.19 | 4.20 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | 7.51 | 6.60 | 4.97 | 4.99 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | 0.45 | 0.24 | 0.20 | 0.38 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 15.62 | 10.23 | 11.93 | 11.24 |
| Neuronetics, Inc. (STIM)vs › | $153.79M | 1.88 | 1.94 | 2.90 | 3.95 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 2.47 | 5.27 | 13.16 | 16.37 |
| Codexis, Inc. (CDXS)vs › | $146.28M | 3.06 | 4.00 | 3.48 | 4.36 |
Current Ratio
5.55
Quick Ratio
5.55
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.55 |
| 2026-03-31 | 4.39 |
| 2025-12-31 | 4.16 |
| 2025-09-30 | 3.89 |
| 2025-06-30 | 2.46 |
| 2025-03-31 | 3.26 |
| 2024-12-31 | 4.52 |
| 2024-09-30 | 2.49 |
| 2024-06-30 | 2.39 |
| 2024-03-31 | 2.81 |
| 2023-12-31 | 4.36 |
| 2023-09-30 | 5.29 |
| 2023-06-30 | 5.54 |
| 2023-03-31 | 7.32 |
| 2022-12-31 | 6.27 |
| 2022-09-30 | 7.02 |
| 2022-06-30 | 6.48 |
| 2022-03-31 | 7.75 |
| 2021-12-31 | 7.53 |
| 2021-09-30 | 12.03 |
| 2021-06-30 | 12.27 |
| 2021-03-31 | 7.31 |
| 2020-12-31 | 5.94 |
| 2020-09-30 | 12.56 |
| 2020-06-30 | 22.14 |
| 2020-03-31 | 17.64 |
| 2019-12-31 | 20.81 |
| 2019-09-30 | 11.39 |
| 2019-06-30 | 24.67 |
| 2019-03-31 | 22.80 |
| 2018-12-31 | 11.22 |
| 2018-09-30 | 3.33 |
| 2018-06-30 | 9.81 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 14.06 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
